Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
July 10, 2026
Thermo Fisher is asking a Delaware court to prevent a former executive's move to a direct competitor following its $8.875 billion acquisition of Clario in March 2026, saying the new leadership role is in violation of contractual obligations negotiated as part of the acquisition.
-
July 10, 2026
DuPont entity and spinoff Chemours Inc. has told a North Carolina federal court it shouldn't have to face a PFAS contamination suit from a state resident, saying in her early-stage court filings, she's conceded that her "equity action" is doomed to fail.
-
July 10, 2026
The U.S. Department of Justice asked the Ninth Circuit to review a California federal court's order blocking the government from trying to identify individuals who received gender-affirming care from a Stanford Medicine hospital as minors.
-
July 10, 2026
Pennsylvania-based medical device company AdaptHealth Corp. is facing a putative class action in federal court alleging the company was liable for a data breach last month that exposed the sensitive information of its customers.
-
July 10, 2026
An analysis of the 67 ex parte reexaminations used to challenge biologics patents over the last 13 years reveals that reexamination may emerge as an alternative to inter partes review and postgrant review, despite facing a number of procedural disadvantages, say attorneys at Steptoe.
See more Life Sciences news